|1.||Smyth, Mark J: 18 articles (10/2013 - 01/2002)|
|2.||Qin, Zhihai: 7 articles (12/2013 - 06/2002)|
|3.||Blankenstein, Thomas: 6 articles (12/2013 - 06/2002)|
|4.||Malkinson, Alvin M: 6 articles (02/2010 - 03/2002)|
|5.||Liu, Mingqiu: 6 articles (01/2009 - 03/2002)|
|6.||El-Kadi, Ayman O S: 5 articles (12/2011 - 09/2004)|
|7.||Chen, Honglei: 5 articles (01/2009 - 03/2002)|
|8.||Hayakawa, Yoshihiro: 5 articles (06/2007 - 01/2002)|
|9.||Li, Honggang: 5 articles (06/2003 - 03/2002)|
|10.||Schreiber, Robert D: 4 articles (08/2012 - 10/2005)|
01/01/1958 - "The administration of 3-methylcholanthrene or androstan-17beta-ol-3-one was only moderately effective in controlling the growth of transplanted mammary tumors characterized by low hormonal dependence; the combined administration of these compounds was highly efficacious in retarding the growth of these refractory tumors. "
08/01/1981 - "This organism was also effective against methylcholanthrene-induced syngeneic MCA K-1 tumor in BALB/c mice. "
01/01/1979 - "However, such cytotoxic T lymphocytes were generated after in vitro stimulation with monolayers of methylcholanthrene-induced tumor cells, UV-irradiated or heated spleen cells which had proved to be effective in secondary but not in primary response. "
09/01/2009 - "An attempt is made in this study to analyze the metabolic patterns of major spliceosomal UsnRNAs, during tumor development, in an in vitro carcinogenesis model of 20-methylcholanthrene (MCA)-transformed Swiss Mouse Embryonic Fibroblast (MEF), designated as CNCI-PM-20. "
11/15/2005 - "Previous studies from our laboratory demonstrated differences in the mutational spectrum induced in the Ki-ras gene from lung tumors isolated from [D2 x B6D2F1]F2 mice and Balb/c mice treated in utero with 3-methylcholanthrene (MC). "
01/01/2002 - "The aim of the study was the evaluation of angiogenesis processes in fibrosarcoma induced by 3-methylcholanthrene (3-Mc) in reference to the number of mast cells (MCs). "
05/01/2001 - "The current experimental work deals with the chemopreventive studies of a hydroalcoholic extract of Withania somnifera roots, against 20-methylcholanthrene induced fibrosarcoma tumours in Swiss albino mice. "
04/01/1997 - "CBA/HZgr mice and methylcholanthrene-induced fibrosarcoma were used in these studies. "
01/01/1990 - "The objective of our study was to determine whether and how frequently MHC class I gene alterations occur in fibrosarcomas induced in BALB/c mice by the carcinogen 3-methylcholanthrene (3-MCA). "
10/15/1989 - "The present study examines clonal variations in NK sensitivity in a methylcholanthrene-induced fibrosarcoma. "
|3.||Sarcoma (Soft Tissue Sarcoma)
06/15/1990 - "Protection from rhTNF toxicity was not associated with any reduction in the therapeutic efficacy of rhTNF against methylcholanthrene-induced sarcomas in either s.c. "
01/01/2015 - "In this study we aimed to decipher the role of NOX2-derived ROS in a chemically (by methylcholanthrene (MCA)) induced sarcoma model. "
03/01/1998 - "In this study we examined 63 methylcholanthrene (MCA)-induced sarcomas from C57BL/6N x C3H/HeN F1 (BCF1) or C3H/HeN x C57BL/6N F1 (CBF1) mice for p53 gene mutations and loss of heterozygosity (LOH) of chromosome 11. "
12/01/1995 - "The present study indicates a possible involvement of K-ras mutation and c-myc amplification in induction of genetic instability in methylcholanthrene-induced mouse sarcomas."
02/15/1994 - "We have utilized a newly developed culture system to study the properties of antitumor CD4+ T-cells relevant to the rejection of syngeneic methylcholanthrene sarcomas. "
|4.||Neoplasm Metastasis (Metastasis)
07/01/2008 - "We inoculated methylcholanthrene (MCA) 205 in the flanks of normal mice and mice bearing MCA 205 lung metastases. "
11/13/1980 - "We now describe principal differences in the expression of H-2 parental haplotypes between a local F1 methylcholanthrene-induced tumour and its descendant pulmonary metastases. "
07/15/1991 - "In the present study, verification of genetic alterations during changes in metastatic behavior was done by analyzing the chromosome composition of a methylcholanthrene induced murine fibrosarcoma, 3AM during multiple cycles of subcutaneous (SC) and intravenous (IV) metastasis. "
10/01/2005 - "CD4+ CD25+ T cells from these IFN-gamma-treated mice failed to exhibit immunosuppressive activity as measured by 1) increased number of pulmonary metastasis, 2) enhanced development of 3-methylcholanthrene-induced primary tumors, 3) suppression of peptide-specific T cell proliferation, and 4) enhanced expression of Foxp3. "
12/01/2001 - "For treatment of 10-day 3-methylcholanthrene 205 pulmonary metastases, systemic transfer of 50 x 10(6) activated tumor-draining lymph node T cells resulted in >99% reduction of metastatic nodules. "
08/01/1991 - "The present report extends these findings and shows that following adoptive immunotherapy (AIT) of mice bearing the immunogenic transplanted methylcholanthrene-induced rhabdomyosarcoma (MCA/76-9) there was a differential expansion of CD4+ and CD8+ TIL, the numbers peaking on days 6 and 8, respectively. "
01/01/1991 - "Appreciable uptake of labelled cage complex was observed in 3-methylcholanthrene induced murine rhabdomyosarcoma."
01/01/1975 - "The ultrastructure of different types of cell elements of rhabdomyosarcoma clones induced by 20-methylcholanthrene in mice CC57W is described. "
03/01/1972 - "[Caryology of rhabdomyosarcomas induced with 3-methylcholanthrene]."
10/01/1959 - "IV. Transplantable methylcholanthrene-induced rhabdomyosarcoma."
|4.||DNA (Deoxyribonucleic Acid)
|5.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
|7.||tumor-associated transplantation antigen (TSTA)
|9.||Complement System Proteins (Complement)
|1.||Heterologous Transplantation (Xenotransplantation)
|4.||Transplantation (Transplant Recipients)